189 related articles for article (PubMed ID: 23679073)
1. Genomic and physiological variability within Group II (non-proteolytic) Clostridium botulinum.
Stringer SC; Carter AT; Webb MD; Wachnicka E; Crossman LC; Sebaihia M; Peck MW
BMC Genomics; 2013 May; 14():333. PubMed ID: 23679073
[TBL] [Abstract][Full Text] [Related]
2. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum.
Carter AT; Paul CJ; Mason DR; Twine SM; Alston MJ; Logan SM; Austin JW; Peck MW
BMC Genomics; 2009 Mar; 10():115. PubMed ID: 19298644
[TBL] [Abstract][Full Text] [Related]
3. Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains.
Hill KK; Xie G; Foley BT; Smith TJ; Munk AC; Bruce D; Smith LA; Brettin TS; Detter JC
BMC Biol; 2009 Oct; 7():66. PubMed ID: 19804621
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes.
Hill KK; Smith TJ
Curr Top Microbiol Immunol; 2013; 364():1-20. PubMed ID: 23239346
[TBL] [Abstract][Full Text] [Related]
5. Pan-Genomic Analysis of
Brunt J; van Vliet AHM; Stringer SC; Carter AT; Lindström M; Peck MW
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32397147
[TBL] [Abstract][Full Text] [Related]
6. Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtype.
Raphael BH; Lautenschlager M; Kalb SR; de Jong LI; Frace M; Lúquez C; Barr JR; Fernández RA; Maslanka SE
BMC Microbiol; 2012 Oct; 12():245. PubMed ID: 23113872
[TBL] [Abstract][Full Text] [Related]
7. Genomes, neurotoxins and biology of Clostridium botulinum Group I and Group II.
Carter AT; Peck MW
Res Microbiol; 2015 May; 166(4):303-17. PubMed ID: 25445012
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomic analyses reveal broad diversity in botulinum-toxin-producing Clostridia.
Williamson CH; Sahl JW; Smith TJ; Xie G; Foley BT; Smith LA; Fernández RA; Lindström M; Korkeala H; Keim P; Foster J; Hill K
BMC Genomics; 2016 Mar; 17():180. PubMed ID: 26939550
[TBL] [Abstract][Full Text] [Related]
9. Biology and genomic analysis of Clostridium botulinum.
Peck MW
Adv Microb Physiol; 2009; 55():183-265, 320. PubMed ID: 19573697
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the botulinum neurotoxin type F gene clusters in proteolytic and nonproteolytic Clostridium botulinum and Clostridium barati.
East AK; Bhandari M; Hielm S; Collins MD
Curr Microbiol; 1998 Oct; 37(4):262-8. PubMed ID: 9732534
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the genes encoding the botulinum neurotoxin complex in a strain of Clostridium botulinum producing type B and F neurotoxins.
Santos-Buelga JA; Collins MD; East AK
Curr Microbiol; 1998 Nov; 37(5):312-8. PubMed ID: 9767710
[TBL] [Abstract][Full Text] [Related]
12. Differentiating Botulinum Neurotoxin-Producing Clostridia with a Simple, Multiplex PCR Assay.
Williamson CHD; Vazquez AJ; Hill K; Smith TJ; Nottingham R; Stone NE; Sobek CJ; Cocking JH; Fernández RA; Caballero PA; Leiser OP; Keim P; Sahl JW
Appl Environ Microbiol; 2017 Sep; 83(18):. PubMed ID: 28733282
[TBL] [Abstract][Full Text] [Related]
13. Genetic diversity within the botulinum neurotoxin-producing bacteria and their neurotoxins.
Hill KK; Xie G; Foley BT; Smith TJ
Toxicon; 2015 Dec; 107(Pt A):2-8. PubMed ID: 26368006
[TBL] [Abstract][Full Text] [Related]
14. Three classes of plasmid (47-63 kb) carry the type B neurotoxin gene cluster of group II Clostridium botulinum.
Carter AT; Austin JW; Weedmark KA; Corbett C; Peck MW
Genome Biol Evol; 2014 Aug; 6(8):2076-87. PubMed ID: 25079343
[TBL] [Abstract][Full Text] [Related]
15. Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes.
Sebaihia M; Peck MW; Minton NP; Thomson NR; Holden MT; Mitchell WJ; Carter AT; Bentley SD; Mason DR; Crossman L; Paul CJ; Ivens A; Wells-Bennik MH; Davis IJ; Cerdeño-Tárraga AM; Churcher C; Quail MA; Chillingworth T; Feltwell T; Fraser A; Goodhead I; Hance Z; Jagels K; Larke N; Maddison M; Moule S; Mungall K; Norbertczak H; Rabbinowitsch E; Sanders M; Simmonds M; White B; Whithead S; Parkhill J
Genome Res; 2007 Jul; 17(7):1082-92. PubMed ID: 17519437
[TBL] [Abstract][Full Text] [Related]
16. Genetic diversity of the flagellin genes of Clostridium botulinum groups I and II.
Woudstra C; Lambert D; Anniballi F; De Medici D; Austin J; Fach P
Appl Environ Microbiol; 2013 Jul; 79(13):3926-32. PubMed ID: 23603687
[TBL] [Abstract][Full Text] [Related]
17. Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain.
Zhou Y; Sugiyama H; Johnson EA
Appl Environ Microbiol; 1993 Nov; 59(11):3825-31. PubMed ID: 8285687
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxin gene clusters in Clostridium botulinum type Ab strains.
Lúquez C; Raphael BH; Maslanka SE
Appl Environ Microbiol; 2009 Oct; 75(19):6094-101. PubMed ID: 19684172
[TBL] [Abstract][Full Text] [Related]
19. The type F6 neurotoxin gene cluster locus of group II clostridium botulinum has evolved by successive disruption of two different ancestral precursors.
Carter AT; Stringer SC; Webb MD; Peck MW
Genome Biol Evol; 2013; 5(5):1032-7. PubMed ID: 23645598
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxin gene clusters in Clostridium botulinum type A strains: sequence comparison and evolutionary implications.
Dineen SS; Bradshaw M; Johnson EA
Curr Microbiol; 2003 May; 46(5):345-52. PubMed ID: 12732962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
